FDA Inspection 1165838 — Mohammad Tahir, MD
The FDA completed an inspection of Mohammad Tahir, MD on Feb 14, 2022 in St. Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- St. Louis, MO (United States)
Additional Details
Clinical Investigator (CI)